Stephen H. Sands - 09 Feb 2024 Form 4 Insider Report for Cyteir Therapeutics, Inc.

Role
Director
Signature
/s/ David Gaiero, as attorney-in-fact for Stephen Sands
Issuer symbol
N/A
Transactions as of
09 Feb 2024
Net transactions value
+$20,498
Form type
4
Filing time
14 Feb 2024, 16:01:23 UTC
Previous filing
07 Feb 2023
Next filing
21 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYT Common Stock Options Exercise $20,498 +12,129 $1.69 12,129 09 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYT Stock Option (Right to Buy) Options Exercise $0 -12,129 -100% $0.000000* 0 09 Feb 2024 Common Stock 12,129 $1.69 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.